Overview
COPD and cardiovascular diseases commonly coexist. In these patients, use of appropriately dosed bronchodilators is safe. In fact, optimized COPD therapy in high-risk patients reduces both respiratory and cardiac mortality.
Faculty
Dr David Price
FRCGP
Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine, University of Aberdeen, UK Managing Director of Observational and Pragmatic Research Institute, Singapore Managing Director of Optimum Patient Care, Australia and UKResources
External Resources
Improving CV Outcomes in COPD
Also Read
Our Research
